Although the PNPLA3 gene variant is associated with a disproportionate development of NAFLD and diabetes, the presence of diabetes in the PNPLA3 gene variant carriers still can amplify the genetic effect to drive the progression of NAFLD (Mitsche et al., 2018). The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.